We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$261M
AUM Growth
-$49.1M
Cap. Flow
+$302K
Cap. Flow %
0.12%
Top 10 Hldgs %
99.7%
Holding
12
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$236K
2
AVDR
Avedro, Inc Common Stock
AVDR
+$65.3K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 57.52%
2 Healthcare 42.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REAL icon
1
The RealReal
REAL
$1.37B
$150M 57.52%
6,704,080
– –
AVDR
2
DELISTED
Avedro, Inc Common Stock
AVDR
$62.3M 23.91%
2,745,244
+3,005
+0.1% +$65.3K
MGNX icon
3
MacroGenics
MGNX
$239M
$13.7M 5.26%
1,074,316
– –
STIM icon
4
Neuronetics
STIM
$125M
$8.56M 3.29%
1,030,689
– –
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$7.84M 3.01%
25,497
– –
AGTC
6
DELISTED
Applied Genetic Technologies Corporation
AGTC
$6.06M 2.32%
1,455,904
– –
KALV
7
DELISTED
KalVista Pharmaceuticals
KALV
$4.51M 1.73%
388,766
– –
VERO
8
DELISTED
Venus Concept
VERO
$3.48M 1.34%
2,164
– –
CDTX
9
DELISTED
Cidara Therapeutics
CDTX
$2.71M 1.04%
67,841
– –
HIND
10
Vyome Holdings
HIND
$14M
– –
0
– –
GKOS icon
11
Glaukos
GKOS
$8.78B
$709K 0.27%
11,351
+3,356
+42% +$236K
XENE icon
12
Xenon Pharmaceuticals
XENE
$6.3B
$75K 0.03%
8,293
– –

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q3 2019 Portfolio in Review

As of Q3 2019, InterWest Venture Management held 12 positions worth $261M, down 16% from $310M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. InterWest Venture Management opened no new positions and made no exits, leaving the 12-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 58% of assets, down from 63% a quarter earlier, followed by Healthcare.

  • InterWest Venture Management added most to Glaukos in Q3 2019, an estimated $236K increase.
  • InterWest Venture Management's ten largest holdings make up 100% of its $261M portfolio in Q3 2019.
  • InterWest Venture Management opened 0 new positions and closed 0 in Q3 2019.
  • InterWest Venture Management's portfolio value fell 16% quarter-over-quarter to $261M.

Based on InterWest Venture Management's 13F filing for Q3 2019, filed 15 Oct 2019.